In conclusion, the presence of dysfunctional CD8+ TRM cells in lesions caused by autoimmune diseases makes the TRM cells subset an important player in the onset and chronic assessment of these diseases and, at the same time, a promising target for new therapeutic strategies in autoimmune diseases. This evidence concerns the gene CD8A and autoimmune disease.